The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Transdermal Drug Delivery Systems Market Research Report 2025

Global Transdermal Drug Delivery Systems Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426342

No of Pages : 94

Ask Your Query

Synopsis

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The global Transdermal Drug Delivery Systems market was valued at US$ 15060 million in 2023 and is anticipated to reach US$ 18990 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery Systems.

Report Scope

The Transdermal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transdermal Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Hisamitsu
  • Mylan
  • GSK
  • Novartis
  • Teve (Actavis)
  • Johnson & Johnson
  • Lohmann
  • Teikoku Seiyaku
  • Bayer
  • Novartis
  • Teve (Actavis)
  • Qizheng
  • Endo
  • Huarun 999
  • Haw Par
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier

Segment by Type

  • Fentanyl
  • Nitroglycerin
  • Estradiol
  • Nicotine
  • Other

Segment by Application

  • OTC
  • Rx

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Systems Market Perspective (2019-2030)
2.2 Transdermal Drug Delivery Systems Growth Trends by Region
2.2.1 Global Transdermal Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transdermal Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Transdermal Drug Delivery Systems Market Dynamics
2.3.1 Transdermal Drug Delivery Systems Industry Trends
2.3.2 Transdermal Drug Delivery Systems Market Drivers
2.3.3 Transdermal Drug Delivery Systems Market Challenges
2.3.4 Transdermal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2023
3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Transdermal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transdermal Drug Delivery Systems Market Size (2019-2030)
6.2 North America Transdermal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transdermal Drug Delivery Systems Market Size by Country (2019-2024)
6.4 North America Transdermal Drug Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Transdermal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transdermal Drug Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Transdermal Drug Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Systems Market Size (2019-2030)
9.2 Latin America Transdermal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transdermal Drug Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Transdermal Drug Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Detail
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.1.5 Hisamitsu Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Systems Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.2.5 Mylan Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery Systems Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Systems Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Detail
11.5.2 Teve (Actavis) Business Overview
11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.5.5 Teve (Actavis) Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Lohmann
11.7.1 Lohmann Company Detail
11.7.2 Lohmann Business Overview
11.7.3 Lohmann Transdermal Drug Delivery Systems Introduction
11.7.4 Lohmann Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.7.5 Lohmann Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Detail
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.8.5 Teikoku Seiyaku Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery Systems Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Transdermal Drug Delivery Systems Introduction
11.10.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Teve (Actavis)
11.11.1 Teve (Actavis) Company Detail
11.11.2 Teve (Actavis) Business Overview
11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
11.11.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.11.5 Teve (Actavis) Recent Development
11.12 Qizheng
11.12.1 Qizheng Company Detail
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.12.5 Qizheng Recent Development
11.13 Endo
11.13.1 Endo Company Detail
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery Systems Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.13.5 Endo Recent Development
11.14 Huarun 999
11.14.1 Huarun 999 Company Detail
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.14.5 Huarun 999 Recent Development
11.15 Haw Par
11.15.1 Haw Par Company Detail
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.15.5 Haw Par Recent Development
11.16 Nichiban
11.16.1 Nichiban Company Detail
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.16.5 Nichiban Recent Development
11.17 Mentholatum
11.17.1 Mentholatum Company Detail
11.17.2 Mentholatum Business Overview
11.17.3 Mentholatum Transdermal Drug Delivery Systems Introduction
11.17.4 Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.17.5 Mentholatum Recent Development
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Detail
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2019-2024)
11.18.5 Laboratoires Genevrier Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock